Clinical trial
Study of Policosanol to Improve High on Clopidogrel Platelet Reactivity After Percutaneous Coronary Stent Implantation(Spirit)
NCT01371058 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Policosanol to Improve High on Clopidogrel Platelet Reactivity After Percutaneous Coronary Stent Implantation(Spirit)
- Lead sponsor
- Shenyang Northern Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- September 30, 2013
- Enrollment
- 350 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.